Roberts Harry W, Maycock Nick J R, OʼBrart David P S
Department of Ophthalmology, Guy's and St. Thomas' NHS Foundation Trust, London, England.
Cornea. 2016 Sep;35(9):1179-81. doi: 10.1097/ICO.0000000000000890.
To report a series of 4 cases (3 patients) with late stromal graft rejection 32 to 46 months after an uneventful deep anterior lamellar keratoplasty (DALK).
Three patients (4 eyes), who had undergone an uneventful DALK for keratoconus (3 eyes) and infectious keratitis (1 eye) 32 to 46 months previously presented with a history of ocular discomfort and redness, with reduced visual acuity in 3 eyes. In all cases, all sutures had been removed at least 18 months previously. On examination, there was superficial and in 2 eyes deep neovascularization. In 2 eyes, the vessels extended within the interface between the donor and host corneas. The stroma of the donor cornea adjacent to the areas of vascularization was edematous. A diagnosis of stromal graft rejection was made, and the patients were administered intensive topical corticosteroids.
All eyes responded well to treatment, becoming more comfortable, with decreasing redness, reversal of corneal edema, and return of prerejection best corrected visual acuity with up to 18 months follow-up. The patients continued to receive tapering dosage of topical corticosteroid for 12 months. In 1 eye topical steroids were reintroduced at 13 months because of a further rejection episode.
These cases of late stromal rejection after DALK provide clinical evidence that donor keratocytes may persist in such lamellar grafts for extended periods and that patients should be warned that rejection may occur years after surgery.
报告4例(3名患者)在深板层角膜移植术(DALK)术后32至46个月发生晚期基质移植排斥反应的病例。
3名患者(4只眼),分别于32至46个月前因圆锥角膜(3只眼)和感染性角膜炎(1只眼)接受了顺利的DALK手术,现出现眼部不适和眼红症状,其中3只眼视力下降。所有病例中,所有缝线至少在18个月前已拆除。检查发现,2只眼有浅层新生血管,2只眼有深层新生血管。2只眼中,血管在供体角膜与宿主角膜之间的界面内延伸。与新生血管区域相邻的供体角膜基质水肿。诊断为基质移植排斥反应,并给予患者强化局部皮质类固醇治疗。
所有患眼对治疗反应良好,眼部舒适度增加,眼红减轻,角膜水肿消退,在长达18个月的随访中,排斥反应前的最佳矫正视力恢复。患者继续接受逐渐减量的局部皮质类固醇治疗12个月。1只眼在13个月时因再次发生排斥反应而重新使用局部类固醇。
这些DALK术后晚期基质排斥反应病例提供了临床证据,表明供体角膜细胞可能在这种板层移植物中长期存活,并且应告知患者术后数年可能发生排斥反应。